Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 43 articles: HTML format

Single Articles

April 2024
1. KATERNDAHL CDS, Rogers ORS, Day RB, Xu Z, et al
   PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells.
   Proc Natl Acad Sci U S A. 2024;121:e2317690121.
   PubMed     Abstract available
   
   
   
2. KRISTENSON L, Badami C, Ljungberg A, Islamagic E, et al
   Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity.
   Proc Natl Acad Sci U S A. 2024;121:e2316447121.
   PubMed     Abstract available
   
   
   March 2024
3. SHICHIJO T, Yasunaga JI, Sato K, Nosaka K, et al
   Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
   Proc Natl Acad Sci U S A. 2024;121:e2309925121.
   PubMed     Abstract available
   
   
   
4. LI JF, Cheng WY, Lin XJ, Wen LJ, et al
   Aging and comprehensive molecular profiling in acute myeloid leukemia.
   Proc Natl Acad Sci U S A. 2024;121:e2319366121.
   PubMed     Abstract available
   
   
   
5. ROSELLE C, Horikawa I, Chen L, Kelly AR, et al
   Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Delta133p53alpha.
   Proc Natl Acad Sci U S A. 2024;121:e2317735121.
   PubMed     Abstract available
   
   
   
6. KATSUMURA KR, Liu P, Kim JA, Mehta C, et al
   Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.
   Proc Natl Acad Sci U S A. 2024;121:e2317147121.
   PubMed     Abstract available
   
   
   February 2024
7. MOTTAGHINIA S, Stenzel S, Tsangaras K, Nikolaidis N, et al
   A recent gibbon ape leukemia virus germline integration in a rodent from New Guinea.
   Proc Natl Acad Sci U S A. 2024;121:e2220392121.
   PubMed     Abstract available
   
   
   October 2023
8. FERLITA A, Nigita G, Tsyba L, Palamarchuk A, et al
   Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia.
   Proc Natl Acad Sci U S A. 2023;120:e2307593120.
   PubMed     Abstract available
   
   
   
9. NG A, Lovat F, Shih AJ, Ma Y, et al
   Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state.
   Proc Natl Acad Sci U S A. 2023;120:e2308658120.
   PubMed     Abstract available
   
   
   August 2023
10. SAUNDERSON EA, Encabo HH, Devis J, Rouault-Pierre K, et al
    CRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and shapes immune progeny.
    Proc Natl Acad Sci U S A. 2023;120:e2300224120.
    PubMed     Abstract available
    
    
    
11. BEAUVOIS A, Gazon H, Chauhan PS, Jamakhani M, et al
    The helicase-like transcription factor redirects the autophagic flux and restricts human T cell leukemia virus type 1 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2216127120.
    PubMed     Abstract available
    
    
    April 2023
12. WRIGHT S, Hu J, Wang H, Hyle J, et al
    Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens.
    Proc Natl Acad Sci U S A. 2023;120:e2220134120.
    PubMed     Abstract available
    
    
    March 2023
13. HUANG D, Zhang C, Xiao M, Li X, et al
    Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells.
    Proc Natl Acad Sci U S A. 2023;120:e2210796120.
    PubMed     Abstract available
    
    
    February 2023
14. YUITA H, Lopez-Moyado IF, Jeong H, Cheng AX, et al
    Inducible disruption of Tet genes results in myeloid malignancy, readthrough transcription, and a heterochromatin-to-euchromatin switch.
    Proc Natl Acad Sci U S A. 2023;120:e2214824120.
    PubMed     Abstract available
    
    
    December 2022
15. CHENG WY, Li JF, Zhu YM, Lin XJ, et al
    Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2211429119.
    PubMed     Abstract available
    
    
    October 2022
16. CHEN Q, Cevher MA, Jiang Q, Wang S, et al
    LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML.
    Proc Natl Acad Sci U S A. 2022;119:e2213718119.
    PubMed     Abstract available
    
    
    September 2022
17. RAHMAN S, Hoffmann NA, Worden EJ, Smith ML, et al
    Multistate structures of the MLL1-WRAD complex bound to H2B-ubiquitinated nucleosome.
    Proc Natl Acad Sci U S A. 2022;119:e2205691119.
    PubMed     Abstract available
    
    
    August 2022
18. ARNOVITZ S, Mathur P, Tracy M, Mohsin A, et al
    Tcf-1 promotes genomic instability and T cell transformation in response to aberrant beta-catenin activation.
    Proc Natl Acad Sci U S A. 2022;119:e2201493119.
    PubMed     Abstract available
    
    
    July 2022
19. KOGAN AA, Topper MJ, Dellomo AJ, Stojanovic L, et al
    Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2123227119.
    PubMed     Abstract available
    
    
    
20. LAFFEY KG, Stiles RJ, Ludescher MJ, Davis TR, et al
    Early expression of mature alphabeta TCR in CD4(-)CD8(-) T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.
    Proc Natl Acad Sci U S A. 2022;119:e2118529119.
    PubMed     Abstract available
    
    
    June 2022
21. MIYAKE A, Ngo MH, Wulandari S, Shimojima M, et al
    Convergent evolution of antiviral machinery derived from endogenous retrovirus truncated envelope genes in multiple species.
    Proc Natl Acad Sci U S A. 2022;119:e2114441119.
    PubMed     Abstract available
    
    
    
22. DONG H, Ham JD, Hu G, Xie G, et al
    Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2122379119.
    PubMed     Abstract available
    
    
    April 2022
23. HOANG DH, Zhao D, Branciamore S, Maestrini D, et al
    MicroRNA networks in FLT3-ITD acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2112482119.
    PubMed     Abstract available
    
    
    
24. DAI YT, Zhang F, Fang H, Li JF, et al
    Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
    Proc Natl Acad Sci U S A. 2022;119:e2120787119.
    PubMed     Abstract available
    
    
    March 2022
25. CHAN LH, Yan Q
    Awakening KDM5B to defeat leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2202245119.
    PubMed    
    
    
    
26. REN Z, Kim A, Huang YT, Pi WC, et al
    A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    January 2022
27. PEPE F, Rassenti LZ, Pekarsky Y, Labanowska J, et al
    A large fraction of trisomy 12, 17p(-), and 11q(-) CLL cases carry unidentified microdeletions of miR-15a/16-1.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    December 2021
28. GUO B, Pomicter AD, Li F, Bhatt S, et al
    Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
29. FERRARO F, Miller CA, Christensen KA, Helton NM, et al
    Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    November 2021
30. LYCZEK A, Berger BT, Rangwala AM, Paung Y, et al
    Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    October 2021
31. GARCIA-GARCIA A, Klein T, Born G, Hilpert M, et al
    Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    August 2021
32. BENSBERG M, Rundquist O, Selimovic A, Lagerwall C, et al
    TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
33. YANG L, Yin J, Wu J, Qiao L, et al
    Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    July 2021
34. WU A, Zhi J, Tian T, Cihan A, et al
    DOT1L complex regulates transcriptional initiation in human erythroleukemic cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    June 2021
35. O'SULLIVAN D, Stanczak MA, Villa M, Uhl FM, et al
    Fever supports CD8(+) effector T cell responses by promoting mitochondrial translation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
36. CHRETIEN AS, Devillier R, Granjeaud S, Cordier C, et al
    High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    April 2021
37. RIVERA OD, Mallory MJ, Quesnel-Vallieres M, Chatrikhi R, et al
    Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    March 2021
38. KU Y, Park JH, Cho R, Lee Y, et al
    Noncanonical immune response to the inhibition of DNA methylation by Staufen1 via stabilization of endogenous retrovirus RNAs.
    Proc Natl Acad Sci U S A. 2021;118:e2016289118.
    PubMed     Abstract available
    
    
    
39. OWEN N, Minko IG, Moellmer SA, Cammann SK, et al
    Enhanced cytarabine-induced killing in OGG1-deficient acute myeloid leukemia cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
40. LOVAT F, Gasparini P, Nigita G, Larkin K, et al
    Loss of expression of both miR-15/16 loci in CML transition to blast crisis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    February 2021
41. WU K, Huynh KQ, Lu I, Moustakim M, et al
    Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
42. PAN L, Hong C, Chan LN, Xiao G, et al
    PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
43. LEE YL, Ito K, Pi WC, Lin IH, et al
    Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.